Bulletin
Investor Alert

BioLife Solutions Inc.

NAS: BLFS

GO
/marketstate/country/us

After Hours

/zigman2/quotes/207858501/composite

$

22.50

Change

0.00 0.00%

Volume

Volume 12,499

May 26, 2023, 4:01 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/207858501/composite

Previous close

$ 22.40

$ 22.50

Change

+0.10 +0.45%

Day low

Day high

$22.26

$22.79

Open
Open: 22.48

52 week low

52 week high

$12.60

$26.96

Open

Market cap

$977.77M

Average volume

295,125

P/E ratio

N/A

Rev. per Employee

$349,555

EPS

-3.41

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/blfs

MarketWatch News on BLFS

  1. BioLife Solutions stock price target cut to $34 from $48 at B. Riley

    7:46 a.m. May 17, 2022

    - Tomi Kilgore

  2. BioLife Solutions stock price target cut to $30 from $60 at Maxim Group

    7:50 a.m. May 12, 2022

    - Tomi Kilgore

  3. BioLife Solutions stock price target cut to $30 from $60 at KeyBanc Capital

    6:35 a.m. May 10, 2022

    - Tomi Kilgore

  4. BioLife Solutions upgraded to outperform from perform at Oppenheimer

    7:28 a.m. April 25, 2022

    - Tomi Kilgore

  5. BioLife Solutions stock price target raised to $60 from $50 at KeyBanc Capital

    6:03 a.m. Aug. 13, 2021

    - Tomi Kilgore

  6. BioLife Solutions stock price target raised to $61.00 from $35.50 at B. Riley

    8:16 a.m. March 24, 2021

    - Tomi Kilgore

  7. BioLife Solutions stock price target raised to $60 from $40 at Maxim Group

    8:20 a.m. March 23, 2021

    - Tomi Kilgore

  8. BioLife Solutions stock price target raised to $50 from $40 at KeyBanc Capital

    6:16 a.m. March 23, 2021

    - Tomi Kilgore

  9. BioLife Solutions, Nikola See Activist Action

    10:31 p.m. Dec. 4, 2020

    - Barron's Online

  10. BioLife Solutions started at overweight with $40 stock price target at KeyBanc Capital

    7:28 a.m. Nov. 10, 2020

    - Tomi Kilgore

  11. BioLife stock price target raised to $40 from $32 at Maxim Group

    9:14 a.m. Nov. 6, 2020

    - Tomi Kilgore

  12. BioLife Solutions downgraded to perform from outperform at Oppenheimer

    8:37 a.m. Sept. 22, 2020

    - Tomi Kilgore

  13. BioLife Solutions downgraded to hold from buy at Benchmark

    6:15 a.m. Aug. 11, 2020

    - Tomi Kilgore

  14. BioLife Solutions stock price target raised to $26 from $18 at Maxim Group

    8:17 a.m. July 8, 2020

    - Tomi Kilgore

  15. BioLife Solutions started at buy with $24 stock price target at Benchmark

    8:42 a.m. Feb. 19, 2020

    - Tomi Kilgore

  16. BioLife Solutions started at outperform with $22 stock price target at Oppenheimer

    8:40 a.m. Nov. 21, 2019

    - Tomi Kilgore

  17. Letters to Barron’s

    9:30 p.m. Oct. 4, 2019

    - Barron's Online

  18. Our Roundtable Experts Pick 14 Biotech Stocks

    6:10 p.m. Oct. 2, 2019

    - Barron's Online

  19. Loading more headlines...
/news/nonmarketwatch/company/us/blfs

Other News on BLFS

  1. 10-Q: BIOLIFE SOLUTIONS INC

    9:08 a.m. May 11, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. This Insider Just Sold Shares of BioLife Solutions Inc

    1:30 p.m. Dec. 31, 2022

    - GuruFocus.com

  3. BioLife Solutions, Inc. (BLFS) Q3 2022 Earnings Call Transcript

    11:08 p.m. Nov. 9, 2022

    - Seeking Alpha

  4. 10-Q: BIOLIFE SOLUTIONS INC

    6:31 p.m. Nov. 9, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  5. Top 5 2nd Quarter Trades of Ranger Investment Management, L.P.

    3:00 p.m. Aug. 15, 2022

    - GuruFocus.com

/news/pressrelease/company/us/blfs

Press Releases on BLFS

  1. BioLife Solutions Reports First Quarter 2023 Financial Results

    4:03 p.m. May 10, 2023

    - PR Newswire - PRF

  2. BioLife Solutions Expands Intellectual Property Estate

    9:05 a.m. Nov. 21, 2022

    - PR Newswire - PRF

  3. BioLife Solutions Reports Third Quarter 2022 Financial Results

    5:05 p.m. Nov. 9, 2022

    - PR Newswire - PRF

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.